Advertisement
Singapore markets close in 3 hours 15 minutes
  • Straits Times Index

    3,279.41
    -13.72 (-0.42%)
     
  • Nikkei

    37,654.88
    -805.20 (-2.09%)
     
  • Hang Seng

    17,261.95
    +60.68 (+0.35%)
     
  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     
  • Bitcoin USD

    64,252.19
    -2,477.14 (-3.71%)
     
  • CMC Crypto 200

    1,385.74
    -38.36 (-2.69%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Gold

    2,329.40
    -9.00 (-0.38%)
     
  • Crude Oil

    82.95
    +0.14 (+0.17%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • FTSE Bursa Malaysia

    1,570.29
    -1.19 (-0.08%)
     
  • Jakarta Composite Index

    7,157.23
    -17.30 (-0.24%)
     
  • PSE Index

    6,580.07
    +7.32 (+0.11%)
     

Don't Buy the Hype: Aurora Cannabis' Transformation Hasn't Worked

Don't Buy the Hype: Aurora Cannabis' Transformation Hasn't Worked

Restructuring and changes in strategy are moves that businesses often deploy when they're facing challenges and headwinds. While Aurora Cannabis (NASDAQ: ACB) has been slashing costs and changing its operations in recent years, the company isn't out of the woods by any stretch. Among the biggest moves that Aurora has made in recent years has been to shift its business more toward medical marijuana.